News Article

In December, the Royal Society of Medicine was host to the Ethos Pharmaceutical Ethics & Compliance Charity Symposium, and this year the focus was AI in Pharma: Writing the Rulebook? The special event, in aid of the charity Bucket List Wishes, brought together leaders in the pharma industry in medical, commercial, compliance, ethics, medical affairs, marketing, data science, and AI.

The symposium set out to examine the ethical and compliance issues surrounding the use of AI in pharma and its potential to transform medicines development and commercialisation.

Candesic Senior Partner Marc Kitten was more than happy to lend his expertise to this fascinating subject and in the name of such a great cause. Marc delivered an insightful presentation on the transformative role of AI in medicines development.

The busy event boasted many brilliant speakers, including the likes of Heather Murray, founder of AI for Non-Techies, who showed us how fast the technologies are progressing towards undistinguishable virtual reality. Thomas Balkizas, Senior Director Enterprise Commercial, UK Pharmaceuticals at Microsoft showed how copilot accelerates time to market and free up creativity.

The speakers also confirmed that many experienced around a 50% gain in productivity using AI, on most activities in the pharma value chain, with the right training.

A big thank you to Ethos Pharmaceutical Ethics & Compliance and, of course, to Dr Nick Broughton for inviting Candesic to be a part of such a great day and for such a wonderful cause.